Sevoflurane postconditioning reduces myocardial reperfusion injury in rat isolated hearts via activation of PI3K/Akt signaling and modulation of Bcl-2 family proteins.
Sevoflurane postconditioning reduces myocardial infarct size. The objective of this study was to examine the role of the phosphatidylinositol-3-kinase (PI3K)/Akt pathway in anesthetic postconditioning and to determine whether PI3K/Akt signaling modulates the expression of pro- and antiapoptotic proteins in sevoflurane postconditioning. Isolated and perfused rat hearts were prepared first, and then randomly assigned to the following groups: Sham-operation (Sham), ischemia/reperfusion (Con), sevoflurane postconditioning (SPC), Sham plus 100 nmol/L wortmannin (Sham+Wort), Con+Wort, SPC+Wort, and Con+dimethylsulphoxide (DMSO). Sevoflurane postconditioning was induced by administration of sevoflurane (2.5%, v/v) for 10 min from the onset of reperfusion. Left ventricular developed pressure (LVDP), left ventricular end-diastolic pressure (LVEDP), maximum increase in rate of LVDP (+dP/dt), maximum decrease in rate of LVDP (-dP/dt), heart rate (HR), and coronary flow (CF) were measured at baseline, R30 min (30 min of reperfusion), R60 min, R90 min, and R120 min. Creatine kinase (CK) and lactate dehydrogenase (LDH) were measured after 5 min and 10 min reperfusion. Infarct size was determined by triphenyltetrazolium chloride staining at the end of reperfusion. Total Akt and phosphorylated Akt (phospho-Akt), Bax, Bcl-2, Bad, and phospho-Bad were determined by Western blot analysis. Analysis of variance (ANOVA) and Student-Newman-Keuls' test were used to investigate the significance of differences between groups. The LVDP, + or - dP/dt, and CF were higher and LVEDP was lower in the SPC group than in the Con group at all points of reperfusion (P<0.05). The SPC group had significantly reduced CK and LDH release and decreased infarct size compared with the Con group [(22.9 + or - 8)% vs. (42.4 + or - 9.4)%, respectively; P<0.05]. The SPC group also had increased the expression of phospho-Akt, Bcl-2, and phospho-Bad, and decreased the expression of Bax. Wortmannin abolished the cardioprotection of sevoflurane postconditioning. Sevoflurane postconditioning may protect the isolated rat heart. Activation of PI3K and modulation of the expression of pro- and antiapoptotic proteins may play an important role in sevoflurane-induced myocardial protection.
Yu
Li-na
LN
Department of Anesthesiology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
Yu
Jing
J
Zhang
Feng-jiang
FJ
Yang
Mei-juan
MJ
Ding
Ting-ting
TT
Wang
Jun-kuan
JK
He
Wei
W
Fang
Tao
T
Chen
Gang
G
Yan
Min
M
D000730:Androstadienes / Q000494:pharmacology; D018685:Anesthetics, Inhalation / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D001794:Blood Pressure / Q000502:physiology; D015153:Blotting, Western; D003402:Creatine Kinase / Q000032:analysis; D006339:Heart Rate / Q000502:physiology; D007166:Immunosuppressive Agents / Q000494:pharmacology; D066298:In Vitro Techniques; D057775:Ischemic Postconditioning / Q000379:methods* / Q000592:standards; D007770:L-Lactate Dehydrogenase / Q000032:analysis; D008297:Male; D008738:Methyl Ethers / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D015428:Myocardial Reperfusion Injury / Q000188:drug therapy* / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D000077149:Sevoflurane; D015398:Signal Transduction / Q000502:physiology; D017725:Ventricular Pressure / Q000502:physiology; D000077191:Wortmannin
D000730:Androstadienes; D018685:Anesthetics, Inhalation; D007166:Immunosuppressive Agents; D008738:Methyl Ethers; D019253:Proto-Oncogene Proteins c-bcl-2; D000077149:Sevoflurane; D007770:L-Lactate Dehydrogenase; D051057:Proto-Oncogene Proteins c-akt; D003402:Creatine Kinase; D000077191:Wortmannin
J Pharmacol Exp Ther. 2004 May;309(2):560-7
14747612
Circulation. 2004 Jun 22;109(24):3042-9
15184284
Circ Res. 2004 Aug 6;95(3):230-2
15242972
J Anesth. 2010 Apr;24(2):215-24
20177944
Anesth Analg. 2006 May;102(5):1355-60
16632808
Anesth Analg. 2006 Dec;103(6):1400-5
17122210
Mol Biol Rep. 2010 Jun;37(5):2439-46
19693689
J Biol Chem. 1997 Sep 26;272(39):24101-4
9305851
Cardiovasc Res. 2000 Feb;45(3):661-70
10728387
Cardiovasc Res. 2000 Feb;45(3):549-59
10728376
Anesthesiology. 2005 Nov;103(5):987-95
16249673
Basic Res Cardiol. 1998 Apr;93(2):85-9
9601573
Cell. 1996 Nov 15;87(4):619-28
8929531
Basic Res Cardiol. 1998 Apr;93(2):71-84
9601572
Science. 1998 Aug 28;281(5381):1322-6
9735050
Cardiovasc Res. 2000 Feb;45(3):651-60
10728386
Circulation. 1996 Oct 1;94(7):1506-12
8840837
Anesthesiology. 2005 Jan;102(1):102-9
15618793
Br J Anaesth. 2001 Dec;87(6):905-11
11878695
Anesth Analg. 2007 Aug;105(2):316-24
17646483
J Mol Cell Cardiol. 2000 Feb;32(2):197-208
10722797
Can J Anaesth. 2006 Feb;53(2):174-82
16434759
Circulation. 2000 Feb 15;101(6):660-7
10673259
Acta Pharmacol Sin. 2008 Aug;29(8):931-41
18664326
Science. 2002 May 31;296(5573):1655-7
12040186
Clin Exp Pharmacol Physiol. 2008 Sep;35(9):1043-51
18505453
Cell. 1997 Oct 17;91(2):231-41
9346240
Br J Anaesth. 1998 Dec;81(6):905-12
10211018
Anesth Analg. 2005 Oct;101(4):942-949
16192500
Circulation. 1997 Sep 2;96(5):1580-5
9315550
Circulation. 2001 Jul 17;104(3):330-5
11457753
Br J Anaesth. 1998 Dec;81(6):913-9
10211019
Circ Res. 1999 May 14;84(9):1043-9
10325241
Can J Anaesth. 1999 Nov;46(11):1076-81
10566931
Anesth Analg. 2005 Dec;101(6):1590-1596
16301224
Life Sci. 2007 Sep 22;81(15):1223-7
17915258
Anesth Analg. 2006 May;102(5):1348-54
16632807
Circ Res. 1998 Jun 15;82(11):1111-29
9633912
Biochem Biophys Res Commun. 2004 Apr 2;316(2):484-9
15020243
J Zhejiang Univ Sci B. 2008 Feb;9(2):100-8
18257131
J Pharmacol Exp Ther. 2006 Jul;318(1):186-94
16551837
Anesth Analg. 2005 Nov;101(5):1252-1260
16243977
Am J Physiol Heart Circ Physiol. 2003 Jan;284(1):H268-76
12388275
Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H971-6
15358610
Cardiovasc Res. 2004 Feb 15;61(3):448-60
14962476